Our centers provide a virtual umbrella for uniting research interests related to a particular disease or technology.
Our cancer center is one of only seven National Cancer Institute (NCI)–designated research centers in the U.S. The distinction conveys scientific leadership, resources, and depth and breadth of basic science research. We have an active Community Advisory Board that is involved in patient advocacy, support our mission and educate the public about what we do.
Translational research and drug development activities by faculty in this center are focused on autoimmune diseases and cancer. Many faculty have multi-year collaborations with leading pharmaceutical companies that lead to clinical trials for novel compounds addressing unmet medical needs.
Diseases associated with aging are a leading cause of disability and death, and their prevalence is rising fast. This center’s mission is to translate discoveries into new treatments to extend healthy lifespans and combat devastating neurologic and cardiac diseases.
Genetic diseases in children are rare, and often incurable. The faculty at this center provide insights into the genes and environmental factors that play a role in the development of childhood diseases. Their work leads to better ways to accurately diagnose, treat and cure children and young people.
The Prebys Center is staffed with experts in assay development, high-throughput screening and lead optimization. It’s one of four comprehensive probe/discovery centers of the NIH Molecular Libraries Probe Production Center Network, and one of seven comprehensive centers in the NCI’s Chemical Biology Consortium.
This center serves as a liaison between our Institute and the outside researchers in the regenerative medicine space. Collaborations among scientists, clinicians, trainees and the private sector are encouraged. The center also provides training, cells, reagents, consultative data management services and human-induced pluripotent stem cells (hiPSCs) for researchers.